Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mol Med
2006 Jan 01;1211-12:328-33. doi: 10.2119/2006–00099.Lund.
Show Gene links
Show Anatomy links
Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity.
Lund FE
.
???displayArticle.abstract???
The 5th international CD38 meeting, held in Torino, Italy, spanned a range of topics from the role of CD38 as a signaling receptor in lymphocytic tumors to the importance of CD38-derived metabolites in NAD(+) metabolism, calcium signaling, and immune function. This meeting was particularly exciting as data were presented demonstrating that collaborative experiments between enzymologists, biochemists, cell biologists, immunologists, and clinicians have started to unravel the secrets of CD38 biology. It is now clear that all of the products of the CD38 enzyme reaction regulate calcium signal transduction in cell types as diverse as sea urchin oocytes and mammalian lymphocytes. It is also apparent that CD38 plays important immunomodulatory role(s), however there is still much debate on how CD38 mediates its immunoregulatory functions and whether the enzymatic products generated by CD38 are important for immunity. The data presented at this meeting have begun to resolve some of these controversies. First, CD38 regulates the function of leukocytes by enzyme-dependent and enzyme-independent mechanisms. Second, CD38 regulates inflammatory responses by modulating the activity of the responding leukocytes and by altering the activity of non-hematopoietic cells in the inflamed tissue. Finally, crosstalk between CD38 and other NAD(+) utilizing enzymes such as ART2, SIRT1, and PARP-1 impacts NAD(+) homeostasis, inflammation, and immunity. Thus, immunity is regulated by CD38 in multiple and unexpected ways and the new research challenge will be to determine whether we can exploit the complex biology of CD38 to therapeutically regulate the immune system.
???displayArticle.pubmedLink???
17380200
???displayArticle.pmcLink???PMC1829203 ???displayArticle.link???Mol Med
Aksoy,
Regulation of intracellular levels of NAD: a novel role for CD38.
2006, Pubmed
Aksoy,
Regulation of intracellular levels of NAD: a novel role for CD38.
2006,
Pubmed
Aksoy,
Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38.
2006,
Pubmed
Alexopoulou,
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
2001,
Pubmed
Aswad,
High sensitivity of CD4+CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors.
2005,
Pubmed
Beck,
Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes.
2006,
Pubmed
Berthelier,
Human CD38 is an authentic NAD(P)+ glycohydrolase.
1998,
Pubmed
Bordone,
Calorie restriction, SIRT1 and metabolism: understanding longevity.
2005,
Pubmed
Chen,
Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion.
2006,
Pubmed
Clapper,
Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol trisphosphate.
1987,
Pubmed
,
Echinobase
Cockayne,
Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses.
1998,
Pubmed
Deaglio,
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
2006,
Pubmed
Deshpande,
CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle.
2005,
Pubmed
Deshpande,
Altered airway responsiveness in CD38-deficient mice.
2005,
Pubmed
Fernàndez,
Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues.
1998,
Pubmed
Guedes,
CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge.
2006,
Pubmed
Guse,
Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose.
1999,
Pubmed
Guse,
Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR).
2005,
Pubmed
Guse,
Regulation of calcium signaling by the second messenger cyclic adenosine diphosphoribose (cADPR).
2004,
Pubmed
Hara,
LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death.
2002,
Pubmed
Harada,
Expression cloning of a cDNA encoding a novel murine B cell activation marker. Homology to human CD38.
1993,
Pubmed
Hoshino,
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
1999,
Pubmed
Howard,
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.
1993,
Pubmed
Höpken,
All roads lead to Rome: triggering dendritic cell migration.
2004,
Pubmed
Johnson,
Suppressed insulin signaling and increased apoptosis in CD38-null islets.
2006,
Pubmed
Kato,
CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2+]i, and insulin secretion.
1999,
Pubmed
Koch-Nolte,
ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells.
2006,
Pubmed
Kolisek,
Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels.
2005,
Pubmed
Krebs,
CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.
2005,
Pubmed
Krieg,
CpG motifs in bacterial DNA trigger direct B-cell activation.
1995,
Pubmed
Lee,
Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers.
2001,
Pubmed
Lee,
A derivative of NADP mobilizes calcium stores insensitive to inositol trisphosphate and cyclic ADP-ribose.
1995,
Pubmed
,
Echinobase
Lee,
Structural determination of a cyclic metabolite of NAD+ with intracellular Ca2+-mobilizing activity.
1989,
Pubmed
,
Echinobase
Liu,
Crystal structure of human CD38 extracellular domain.
2005,
Pubmed
Lund,
Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
1996,
Pubmed
Lund,
CD38: a new paradigm in lymphocyte activation and signal transduction.
1998,
Pubmed
Lund,
Recognition of single-stranded RNA viruses by Toll-like receptor 7.
2004,
Pubmed
Lund,
CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism.
2006,
Pubmed
McHugh,
Critical intracellular Ca2+ dependence of transient receptor potential melastatin 2 (TRPM2) cation channel activation.
2003,
Pubmed
Moreno-García,
CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade.
2005,
Pubmed
Muller-Steffner,
Slow-binding inhibition of NAD+ glycohydrolase by arabino analogues of beta-NAD.
1992,
Pubmed
Muñoz,
CD38 signaling in T cells is initiated within a subset of membrane rafts containing Lck and the CD3-zeta subunit of the T cell antigen receptor.
2003,
Pubmed
Partida-Sánchez,
Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo.
2001,
Pubmed
Partida-Sánchez,
Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity.
2003,
Pubmed
Partida-Sánchez,
Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose.
2004,
Pubmed
Partida-Sánchez,
Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity.
2004,
Pubmed
Pavón,
Increased association of CD38 with lipid rafts in T cells from patients with systemic lupus erythematosus and in activated normal T cells.
2006,
Pubmed
Perraud,
ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology.
2001,
Pubmed
Potter,
Medicinal chemistry and pharmacology of cyclic ADP-ribose.
2004,
Pubmed
Sano,
Immunocyte Ca2+ influx system mediated by LTRPC2.
2001,
Pubmed
Santos-Argumedo,
A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels.
1993,
Pubmed
Santos-Argumedo,
CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.
1995,
Pubmed
Schuber,
Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites.
2004,
Pubmed
Seman,
NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor.
2003,
Pubmed
Seman,
Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling.
2004,
Pubmed
Shen,
The crystal structure and mutational analysis of human NUDT9.
2003,
Pubmed
Togashi,
TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion.
2006,
Pubmed
Yasue,
IgG1 production by sIgD+ splenic B cells and peritoneal B-1 cells in response to IL-5 and CD38 ligation.
1999,
Pubmed
Young,
Decreased cADPR and increased NAD+ in the Cd38-/- mouse.
2006,
Pubmed
Zubiaur,
CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs.
2002,
Pubmed
